Predicting the development of acute respiratory distress syndrome: Searching for the "troponin of ARDS"

American Journal of Respiratory and Critical Care Medicine

Volumn 187, Issue 7, 2013, Pages 671-672

  Laffey, John G ^a,b   Talmor, Daniel ^c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ADULT RESPIRATORY DISTRESS SYNDROME; APACHE; ARTIFICIAL VENTILATION; CELL MEMBRANE PERMEABILITY; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CRITICALLY ILL PATIENT; DISEASE MARKER; EDITORIAL; EMERGENCY WARD; HEART MUSCLE ISCHEMIA; HOSPITAL ADMISSION; HUMAN; LUNG INJURY; MORTALITY; PATHOPHYSIOLOGY; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SEPSIS; SHOCK; THERAPY EFFECT;

ACUTE LUNG INJURY; ANGIOPOIETIN-2; FEMALE; HUMANS; INTERLEUKIN-8; MALE; RECEPTORS, IMMUNOLOGIC; VON WILLEBRAND FACTOR;

EID: 84875839921     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201301-0168ED     Document Type: Editorial

References (10)

1. Frieden TR, Berwick DM. The "million hearts" initiative-preventing heart attacks and strokes. N Engl J Med 2011;365:e27.
2. Li G, Malinchoc M, Cartin-Ceba R, Venkata CV, Kor DJ, Peters SG, Hubmayr RD, Gajic O. Eight-year trend of acute respiratory distress syndrome: a population-based study in Olmsted County, Minnesota. Am J Respir Crit Care Med 2011;183:59-66.
3. Calfee CS, Ware LB, Glidden DV, Eisner MD, Parsons PE, Thompson BT, Matthay MA. Use of risk reclassification with multiple biomarkers improves mortality prediction in acute lung injury. Crit Care Med 2011; 39:711-717.
4. Agrawal A, Matthay MA, Kangelaris KN, Stein J, Chu JC, Imp BM, Cortez A, Abbott J, Liu KD, Calfee CS. Plasma angiopoietin-2 predicts the onset of acute lung injury in critically ill patients. Am J Respir Crit Care Med 2013;187:736-742.
5. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, Hou P, Anderson H III, Hoth JJ, Mikkelsen ME, Gentile NT, et al. Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 2011; 183:462-470.
6. Gallagher DC, Parikh SM, Balonov K, Miller A, Gautam S, Talmor D, Sukhatme VP. Circulating angiopoietin 2 correlates with mortality in a surgical population with acute lung injury/adult respiratory distress syndrome. Shock 2008;29:656-661.
7. David S, Mukherjee A, Ghosh CC, Yano M, Khankin EV, Wenger JB, Karumanchi SA, Shapiro NI, Parikh SM. Angiopoietin-2 may contribute to multiple organ dysfunction and death in sepsis. Crit Care Med 2012;40:3034-3041.
8. van der Heijden M, van Nieuw Amerongen GP, Koolwijk P, van Hinsbergh VW, Groeneveld AB. Angiopoietin-2, permeability oedema, occurrence and severity of ALI/ARDS in septic and non-septic critically ill patients. Thorax 2008;63:903-909.
9. Spragg RG, Bernard GR, Checkley W, Curtis JR, Gajic O, Guyatt G, Hall J, Israel E, Jain M, Needham DM, et al. Beyond mortality: future clinical research in acute lung injury. Am J Respir Crit Care Med 2010; 181:1121-1127.
10. Kor DJ, Talmor DS, Banner-Goodspeed VM, Carter RE, Hinds R, Park PK, Gajic O, Gong MN. Lung injury prevention with aspirin (LIPS-A): a protocol for a multicentre randomised clinical trial in medical patients at high risk of acute lung injury. BMJ Open 2012;2:e001606.